Photoirritation and Photoallergic Potential of a New Nicotine Patch

PHASE1CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Smoking Cessation
Interventions
DRUG

Nicotine Patch

25 mg nicotine patch applied on the assigned marked site on the lower back or buttock. Induction (23 days): six treatment applications for 24 h. Challenge (five days): one treatment application for 24 h.

DRUG

Placebo Patch

As a positive control, a placebo patch applied on the assigned marked site on the lower back or buttock. Induction (23 days): six treatment applications for 24 h. Challenge (five days): one treatment application for 24 h.

DRUG

No Patch Control

As a negative control, a marked site on the lower back or buttock was assigned as test area, but no patch was applied.

RADIATION

UVA and UVB irradiation

All three test sites exposed to UV radiation after patch removal. Induction: 10 J/cm2 UVA and 0.5 MED UVB, one treatment after first patch removal; and 3 MED UVB at the 5 following treatments. Challenge: 4 J/cm2 UVA and 0.5MED UVB, one treatment.( MED: Minimal Erythema Dose determined during screening)

Trial Locations (1)

68167

IKP GmbH, Mannheim

Sponsors

Lead Sponsor

All Listed Sponsors
lead

McNeil AB

INDUSTRY